Pioneering 3D Human Tissues for Drug Discovery
Apr 02 | 2025
Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements
Read More »Mar 27 | 2025
Organovo Provides Business Update
Read More »Mar 25 | 2025
Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company
Read More »
